ArticleHistochemistry and cell biology2025
Excessive intake of fructose and alcohol aggravates high-fat diet-induced steatohepatitis and changes hepatic iron homeostasis.
Article in Histochemistry and cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- The convergent roles of metabolic dysfunction, alcohol, and iron in steatotic liver disease: a review.Bioscience reports · 2026Review
- Vitamin E treatment modulates steatotic and attenuates oxidative stress in a MASLD in vitro model.Molecular biology reports · 2026Article
- Dendrobium officinale polysaccharide ameliorate hyperlipidemia through LKB1/AMPK and CD36/PGC-1α/UCP1 activation and gut microbiota modulation.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- GCKR genetic variants and circulating FGF21 identify a metabolic risk signature in metabolic dysfunction-associated steatotic liver disease.BMC gastroenterology · 2026Article
- Pemafibrate therapy increases serum zinc levels in patients with metabolic dysfunction-associated steatohepatitis: a prospective study.BMC gastroenterology · 2026Article
- GATA2 deficiency exacerbates chronic liver injuryWorld journal of stem cells · 2026Article
- Comparative study of obeticholic acid and rosuvastatin in high-fat/fructose diet-induced metabolic dysfunction: role of AMPK, PPAR-γ, SREBP-1c, and STAT3 pathways.Journal of molecular histology · 2026Article
- Cirrhosis outcomes on rurality and weekend admissions revisited: A contemporary analysis of the national inpatient sample.PloS one · 2026Article
- Targeting lipocalin-2 in atherosclerosis: biological functions, pathogenic mechanisms, and therapeutic potential.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatocytes play a vital role in maintaining iron homeostasis, which can be compromised by poor diet and lifestyle. This study aimed to assess the combined impact of high-fat diet (HFD), alcohol, and fructose intake on liver injury and iron metabolism. Male Sprague-Dawley rats (5‒7 weeks old, weighing 160‒180 g) were randomly assigned to three groups: regular chow, HFD, and a combined HFD with 30% ethanol and 30% fructose (HF‒EFr), and were maintained for 4 or 8 weeks. Liver injury was assessed via histopathological staining and serum aminotransferase levels. Iron homeostasis was evaluated by measuring plasma iron levels, hepatic iron deposition, and the expression of key iron-regulatory proteins. Markers of inflammation, oxidative stress, and macrophage activation, such as CD14, ED-1 (CD68), HIF1α, and STAT3 activation, were also examined. Urinary levels of ferritin-L and lipocalin-2 were measured. The HF‒EFr group exhibited severe liver injury, characterized by steatohepatitis and hepatocyte ballooning, with significantly elevated serum aminotransaminase levels and a decrease in the AST/ALT ratio from 3:1 at week 4 to 2:1 at week 8, indicative of progressive hepatocellular damage. Increased serum CD14 and hepatic ED-1 (CD68) confirmed macrophage activation. Urinary ferritin-L and lipocalin-2 levels increased significantly compared with other groups, indicating systemic inflammation and renal involvement. In the HF‒EFr group, gene expression of ferroportin and ferritin was upregulated, accompanied by plasma iron depletion and increased hepatic iron deposition. Nuclear localization of ferritin subunits in hepatocytes was observed, along with elevated HIF-1α and cytokine levels, and activation of STAT3, suggesting an oxidative stress response in the HF‒EFr group. Chronic consumption of alcohol and fructose intensifies the dysregulation of iron metabolism and liver injury induced by a high-fat diet. These findings highlight the critical role of iron homeostasis in diet-induced liver disease and suggest that urinary biomarkers such as ferritin-L and lipocalin-2 may serve as noninvasive indicators of systemic inflammation and iron dysregulation. This study underscores the need for early detection strategies and long-term dietary interventions to limit metabolic liver disease progression.
Indexed as
Identifiers
40745231What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.